Targeting Oxidative Stress and Aberrant Critical Period Plasticity in the Developmental Trajectory to Schizophrenia
Schizophrenia is a neurodevelopmental disorder reflecting a convergence of genetic risk and early life stress. The slow progression to first psychotic episode represents both a window of vulnerability as well as opportunity for therapeutic intervention. Here, we consider recent neurobiological insig...
Saved in:
Published in | Schizophrenia bulletin Vol. 41; no. 4; pp. 835 - 846 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
Oxford University Press
01.07.2015
|
Subjects | |
Online Access | Get full text |
ISSN | 0586-7614 1745-1701 1745-1701 |
DOI | 10.1093/schbul/sbv065 |
Cover
Abstract | Schizophrenia is a neurodevelopmental disorder reflecting a convergence of genetic risk and early life stress. The slow progression to first psychotic episode represents both a window of vulnerability as well as opportunity for therapeutic intervention. Here, we consider recent neurobiological insight into the cellular and molecular components of developmental critical periods and their vulnerability to redox dysregulation. In particular, the consistent loss of parvalbumin-positive interneuron (PVI) function and their surrounding perineuronal nets (PNNs) as well as myelination in patient brains is consistent with a delayed or extended period of circuit instability. This linkage to critical period triggers (PVI) and brakes (PNN, myelin) implicates mistimed trajectories of brain development in mental illness. Strategically introduced antioxidant treatment or later reinforcement of molecular brakes may then offer a novel prophylactic psychiatry. |
---|---|
AbstractList | Schizophrenia is a neurodevelopmental disorder reflecting a convergence of genetic risk and early life stress. The slow progression to first psychotic episode represents both a window of vulnerability as well as opportunity for therapeutic intervention. Here, we consider recent neurobiological insight into the cellular and molecular components of developmental critical periods and their vulnerability to redox dysregulation. In particular, the consistent loss of parvalbumin-positive interneuron (PVI) function and their surrounding perineuronal nets (PNNs) as well as myelination in patient brains is consistent with a delayed or extended period of circuit instability. This linkage to critical period triggers (PVI) and brakes (PNN, myelin) implicates mistimed trajectories of brain development in mental illness. Strategically introduced antioxidant treatment or later reinforcement of molecular brakes may then offer a novel prophylactic psychiatry. Schizophrenia is a neurodevelopmental disorder reflecting a convergence of genetic risk and early life stress. The slow progression to first psychotic episode represents both a window of vulnerability as well as opportunity for therapeutic intervention. Here, we consider recent neurobiological insight into the cellular and molecular components of developmental critical periods and their vulnerability to redox dysregulation. In particular, the consistent loss of parvalbumin-positive interneuron (PVI) function and their surrounding perineuronal nets (PNNs) as well as myelination in patient brains is consistent with a delayed or extended period of circuit instability. This linkage to critical period triggers (PVI) and brakes (PNN, myelin) implicates mistimed trajectories of brain development in mental illness. Strategically introduced antioxidant treatment or later reinforcement of molecular brakes may then offer a novel prophylactic psychiatry.Schizophrenia is a neurodevelopmental disorder reflecting a convergence of genetic risk and early life stress. The slow progression to first psychotic episode represents both a window of vulnerability as well as opportunity for therapeutic intervention. Here, we consider recent neurobiological insight into the cellular and molecular components of developmental critical periods and their vulnerability to redox dysregulation. In particular, the consistent loss of parvalbumin-positive interneuron (PVI) function and their surrounding perineuronal nets (PNNs) as well as myelination in patient brains is consistent with a delayed or extended period of circuit instability. This linkage to critical period triggers (PVI) and brakes (PNN, myelin) implicates mistimed trajectories of brain development in mental illness. Strategically introduced antioxidant treatment or later reinforcement of molecular brakes may then offer a novel prophylactic psychiatry. |
Author | Hensch, Takao K. Cuenod, Michel Do, Kim Q. |
Author_xml | – sequence: 1 givenname: Kim Q. surname: Do fullname: Do, Kim Q. – sequence: 2 givenname: Michel surname: Cuenod fullname: Cuenod, Michel – sequence: 3 givenname: Takao K. surname: Hensch fullname: Hensch, Takao K. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26032508$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc1rGzEQxUVJaJy0x16Ljr1so6_Vri6F4DRpIZBA3LPQaideBVlyJdnU_eur4KQ0IdDTwMxvHo_3jtFBiAEQ-kDJZ0oUP812Gjb-NA9bIts3aEY70Ta0I_QAzUjby6aTVByh45zvCaFCSfYWHTFJOGtJP0N5YdISigtLfP3Ljaa4LeDbkiBnbMKIzwZIyYSC58kVZ43HN5BcHPGNN7kuXNlhF3CZAJ_DFnxcryCUii2SuQdbYtrhEvGtndzvuJ4SBGfeocM74zO8f5wn6MfF18X8W3N1ffl9fnbVWCG60kAviOmJNNwM3aAYl4JZKggHY2nLRcvabiCcKGAUBjNaUAyo6pUcgCg68hP0Za-73gwrqPdQkvF6ndzKpJ2Oxunnl-AmvYxbLYSUVHVV4NOjQIo_N5CLXrlswXsTIG6ypl1NW9VM5f9RWX0x3oq-oh__tfXXz1MpFeB7wKaYc4I7XWOuzcQHl85rSvRD9Xpfvd5XX7-aF19Pwq_zfwD9qbYH |
CitedBy_id | crossref_primary_10_1016_j_schres_2016_11_045 crossref_primary_10_1038_mp_2017_47 crossref_primary_10_1039_C8FO02118J crossref_primary_10_1186_s41983_023_00719_2 crossref_primary_10_3389_fnbeh_2024_1477984 crossref_primary_10_3389_fncel_2023_1186630 crossref_primary_10_1523_JNEUROSCI_1822_17_2017 crossref_primary_10_7554_eLife_39393 crossref_primary_10_1016_j_neuroscience_2017_04_016 crossref_primary_10_1016_j_schres_2019_12_015 crossref_primary_10_1016_j_schres_2015_10_002 crossref_primary_10_1080_01612840_2023_2192794 crossref_primary_10_1093_schbul_sbab030 crossref_primary_10_1016_j_bbr_2020_113016 crossref_primary_10_1186_s12991_020_00308_0 crossref_primary_10_1371_journal_pone_0316384 crossref_primary_10_1016_j_bbrc_2020_03_030 crossref_primary_10_1111_bdi_12401 crossref_primary_10_1155_2016_9847696 crossref_primary_10_1038_npp_2016_24 crossref_primary_10_1038_mp_2016_147 crossref_primary_10_1523_ENEURO_0081_17_2017 crossref_primary_10_1016_j_schres_2019_07_057 crossref_primary_10_1038_s41398_019_0660_x crossref_primary_10_1016_j_pnpbp_2020_110047 crossref_primary_10_1038_s41380_021_01374_w crossref_primary_10_3389_fnmol_2020_00124 crossref_primary_10_1093_schbul_sbv136 crossref_primary_10_1523_ENEURO_0424_20_2021 crossref_primary_10_1038_mp_2017_216 crossref_primary_10_1073_pnas_2123182120 crossref_primary_10_1186_s12916_017_0895_4 crossref_primary_10_1038_s41386_022_01451_w crossref_primary_10_1016_j_psychres_2022_114926 crossref_primary_10_1016_j_psychres_2021_113832 crossref_primary_10_1176_appi_ajp_2019_19080865 crossref_primary_10_1016_j_schres_2024_07_023 crossref_primary_10_1073_pnas_1817222116 crossref_primary_10_1038_s41380_019_0514_1 crossref_primary_10_1007_s40473_019_00174_5 crossref_primary_10_1016_j_neuropharm_2019_05_009 crossref_primary_10_1016_j_schres_2018_10_021 crossref_primary_10_1080_15622975_2023_2198595 crossref_primary_10_1093_schbul_sbw038 crossref_primary_10_1016_j_neuroscience_2016_11_035 crossref_primary_10_1093_schbul_sbw156 crossref_primary_10_1007_s12017_023_08737_2 crossref_primary_10_31887_DCNS_2018_20_2_gcollin crossref_primary_10_1002_1873_3468_12972 crossref_primary_10_2147_DMSO_S308620 crossref_primary_10_1016_j_biopsych_2017_03_005 crossref_primary_10_1016_j_neubiorev_2017_04_028 crossref_primary_10_1016_j_neuint_2017_10_001 crossref_primary_10_1038_s41386_021_01172_6 crossref_primary_10_3389_fcell_2021_663854 crossref_primary_10_1016_j_neulet_2018_06_014 crossref_primary_10_1016_j_neubiorev_2016_05_030 crossref_primary_10_1038_srep37580 crossref_primary_10_1016_j_bbi_2025_01_026 crossref_primary_10_1016_j_cortex_2020_08_015 crossref_primary_10_1080_14728222_2021_1849144 crossref_primary_10_1002_dev_21390 crossref_primary_10_1016_j_phrs_2020_105330 crossref_primary_10_7554_eLife_68590 crossref_primary_10_1038_mp_2017_1 crossref_primary_10_1016_j_arres_2021_100013 crossref_primary_10_1016_j_biopsych_2016_03_1047 crossref_primary_10_1177_0269881119875979 crossref_primary_10_3389_fpsyt_2017_00203 crossref_primary_10_1016_j_neubiorev_2021_10_025 crossref_primary_10_1523_JNEUROSCI_1897_19_2020 crossref_primary_10_1016_j_freeradbiomed_2017_05_025 crossref_primary_10_1186_s13041_017_0328_5 crossref_primary_10_3390_brainsci10100742 crossref_primary_10_3390_life14050578 crossref_primary_10_1186_s13033_020_00356_9 crossref_primary_10_1016_j_schres_2015_10_042 crossref_primary_10_1038_s41380_019_0393_5 crossref_primary_10_1016_j_neures_2021_04_003 crossref_primary_10_3390_antiox12040975 crossref_primary_10_1038_s41398_021_01385_9 crossref_primary_10_1016_j_tins_2019_04_003 crossref_primary_10_1038_s41398_020_01046_3 crossref_primary_10_1002_aur_2312 crossref_primary_10_1038_s41380_019_0423_3 crossref_primary_10_1073_pnas_1820836117 crossref_primary_10_1038_s41398_022_02183_7 crossref_primary_10_1038_s41398_022_02115_5 crossref_primary_10_1016_j_nbd_2018_11_007 crossref_primary_10_1016_j_pharmthera_2018_05_005 crossref_primary_10_1038_s41380_021_01198_8 crossref_primary_10_1038_s41380_023_01979_3 crossref_primary_10_1111_dgd_12571 crossref_primary_10_2174_1568026621666210701105839 crossref_primary_10_1016_j_brainres_2016_07_042 crossref_primary_10_3389_fnmol_2023_1149906 crossref_primary_10_1097_WNF_0000000000000209 crossref_primary_10_1111_cns_12847 crossref_primary_10_1523_JNEUROSCI_1787_22_2023 crossref_primary_10_1016_j_psychres_2023_115064 crossref_primary_10_1111_pcn_12811 crossref_primary_10_1016_j_ijdevneu_2017_08_003 crossref_primary_10_3390_ijms23042125 crossref_primary_10_3389_fpsyt_2021_703452 crossref_primary_10_1002_hup_2880 crossref_primary_10_1016_j_bbagen_2017_06_010 crossref_primary_10_1152_physrev_00018_2017 crossref_primary_10_1016_j_neuroscience_2017_07_016 crossref_primary_10_3389_fnins_2017_00307 crossref_primary_10_1016_j_psc_2020_02_010 crossref_primary_10_3389_fnbeh_2017_00106 crossref_primary_10_1177_0269881119845820 crossref_primary_10_1016_j_euroneuro_2019_07_134 crossref_primary_10_1016_j_pnpbp_2018_11_017 crossref_primary_10_1016_j_phrs_2025_107690 crossref_primary_10_1016_j_neuroimage_2016_07_056 crossref_primary_10_1097_NMD_0000000000000545 crossref_primary_10_1016_j_bcp_2024_116599 crossref_primary_10_3390_biom11081235 crossref_primary_10_1016_j_psyneuen_2022_105854 crossref_primary_10_1186_s13071_022_05596_x crossref_primary_10_1038_s41583_019_0196_3 |
Cites_doi | 10.1523/JNEUROSCI.1666-13.2013 10.1016/j.pneurobio.2010.09.004 10.1046/j.1471-4159.2003.02211.x 10.1038/mp.2011.31 10.1016/j.pneurobio.2010.09.003 10.1038/nn.3023 10.3389/fnsys.2013.00102 10.1016/j.biopsych.2005.05.015 10.1001/archpsyc.60.5.443 10.1016/j.biopsych.2012.01.013 10.1016/j.tips.2013.01.001 10.1523/JNEUROSCI.4166-08.2008 10.1073/pnas.0910302107 10.1007/s00401-011-0881-4 10.1016/j.biopsych.2009.04.033 10.1038/nn.3070 10.1016/B978-0-444-63327-9.00001-1 10.1371/journal.pbio.0050035 10.1523/JNEUROSCI.4104-10.2010 10.1523/JNEUROSCI.0698-10.2010 10.1016/j.biopsych.2011.02.011 10.3389/fnins.2014.00145 10.3389/fnsyn.2014.00028 10.1073/pnas.0908908106 10.1016/j.eurpsy.2007.12.004 10.1158/1078-0432.CCR-09-2937 10.1016/j.celrep.2013.05.014 10.1016/j.neuron.2007.01.031 10.1016/j.biopsych.2011.07.035 10.1016/j.cub.2012.08.012 10.1016/j.biopsych.2011.02.031 10.1016/j.schres.2006.03.029 10.1016/j.neuron.2014.07.028 10.1111/j.1460-9568.2005.04536.x 10.1523/JNEUROSCI.3475-12.2012 10.1016/j.biopsych.2008.03.004 10.1016/j.bbr.2009.07.014 10.1371/journal.pone.0029341 10.1073/pnas.1109625108 10.1016/j.bandc.2011.08.003 10.1016/j.neuron.2011.12.013 10.1016/j.tins.2011.10.004 10.1016/j.biopsych.2011.05.006 10.1046/j.1471-4159.1998.71052071.x 10.1002/(SICI)1098-1136(199804)22:4<371::AID-GLIA6>3.0.CO;2-6 10.1016/j.neuroscience.2013.11.049 10.1111/j.1460-9568.2010.07261.x 10.1038/nature08928 10.1016/j.neuron.2015.02.036 10.1038/nrn1787 10.1126/science.1148045 10.1073/pnas.1200705109 10.1126/science.1161151 10.1111/j.1552-6569.2012.00779.x 10.1016/j.bbi.2007.09.012 10.1111/j.1749-6632.1984.tb12376.x 10.1523/JNEUROSCI.3989-03.2004 10.1016/S0022-3956(03)00095-5 10.1523/JNEUROSCI.4812-10.2010 10.1126/science.1195320 10.1016/j.biopsych.2012.09.020 10.1111/j.1365-2796.2010.02268.x 10.1016/j.schres.2007.04.014 10.1016/S0301-0082(99)00060-X 10.1016/j.etp.2010.11.005 10.1073/pnas.0704774104 10.1007/s11920-012-0346-z 10.1016/j.neuron.2014.08.028 10.1016/j.bbr.2011.10.020 10.1523/JNEUROSCI.4076-05.2006 10.1016/S0920-9964(01)00188-8 10.1159/000354178 10.1093/schbul/sbq105 10.1016/j.nbd.2006.01.003 10.1097/YCO.0b013e32835d9e6a 10.1016/S0920-9964(03)00181-6 10.1016/j.nbd.2005.08.012 10.1016/j.expneurol.2007.12.011 10.1155/2011/174689 10.1016/j.neuron.2012.09.004 10.1523/JNEUROSCI.0545-14.2014 10.1007/s12031-014-0232-8 10.1017/S146114571400056X 10.1046/j.1460-9568.2000.00229.x 10.1007/978-1-61779-157-4_7 10.1159/000346157 10.1073/pnas.081071198 10.1046/j.1471-4159.2003.01580.x 10.1001/archpsyc.65.4.378 10.1016/j.neuropharm.2011.04.019 10.1016/j.neuroimage.2011.07.030 10.1523/JNEUROSCI.0394-12.2012 10.1016/j.psyneuen.2012.07.011 10.1016/S0006-3223(02)01397-5 10.1038/npp.2011.109 10.1038/npp.2013.101 10.1073/pnas.0708710104 10.1038/sj.npp.1301624 10.1073/pnas.0813176106 10.1155/2011/325789 10.1038/nature08002 10.1016/S0197-0186(97)00031-4 10.1016/j.tics.2009.12.002 10.1016/j.biopsych.2013.05.007 10.1016/0304-3940(96)12733-6 10.1172/JCI70317 10.1038/nrn2044 10.1016/j.schres.2014.06.021 10.1001/archpsyc.57.12.1139 10.1212/WNL.0000000000000798 10.1016/j.tins.2007.05.005 10.1038/nrn2774 10.1155/2006/248387 10.1089/ars.2010.3603 10.1017/S1461145710000805 10.1523/JNEUROSCI.3857-09.2010 10.9758/cpn.2012.10.2.94 10.1038/nature07991 10.1016/j.tins.2008.02.005 10.1001/archgenpsychiatry.2009.192 10.1016/S0169-328X(03)00051-2 10.1097/HRP.0000000000000040 10.1089/ars.2012.4858 10.1016/j.bbr.2011.05.017 10.1016/j.biopsych.2013.11.017 10.1093/brain/awq333 10.1016/j.neuron.2010.09.017 10.1007/s11011-013-9433-z 10.1126/science.282.5393.1504 10.1007/s00401-009-0601-5 10.1074/jbc.M110.121327 10.1038/jcbfm.2014.104 10.1016/S0140-6736(03)14289-4 10.1152/ajpcell.00283.2008 10.1007/s00702-007-0627-6 10.1023/A:1020981510759 10.1016/j.schres.2014.05.005 10.1523/JNEUROSCI.0421-12.2012 10.1523/JNEUROSCI.5419-08.2009 10.1016/j.neuroscience.2012.02.017 10.1016/j.biopsych.2011.12.016 10.1016/0006-3223(93)90277-K 10.1111/j.1749-6632.2003.tb07481.x 10.1093/schbul/sbr028 10.1007/s00213-012-2926-3 10.1038/sj.mp.4001325 10.1016/S0006-3223(02)01443-9 10.1073/pnas.112203099 10.4088/JCP.v67n1217 10.1038/npp.2008.19 10.1126/scitranslmed.3010157 10.1001/archgenpsychiatry.2009.196 10.1097/WNF.0000000000000001 10.1016/j.neuron.2012.08.019 10.1523/JNEUROSCI.5286-12.2013 10.1080/15622970903144004 10.1038/nature09552 10.1038/nature12866 10.1073/pnas.1300454110 10.1111/j.1472-8206.2011.00988.x |
ContentType | Journal Article |
Copyright | The Author 2015. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com. The Author 2015. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com 2015 |
Copyright_xml | – notice: The Author 2015. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com. – notice: The Author 2015. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com 2015 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7TK 5PM |
DOI | 10.1093/schbul/sbv065 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Neurosciences Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic Neurosciences Abstracts |
DatabaseTitleList | Neurosciences Abstracts MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1745-1701 |
EndPage | 846 |
ExternalDocumentID | PMC4466197 26032508 10_1093_schbul_sbv065 |
Genre | Review Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIMH NIH HHS grantid: 1P50MH094271 |
GroupedDBID | --- -E4 -~X .2P .GJ .I3 .XZ .ZR 0R~ 123 186 18M 1KJ 1TH 2WC 4.4 48X 53G 5RE 5VS 5WA 5WD 70D 7RV 7RZ 85S 8FI 8FJ AABZA AACZT AAILS AAJKP AAJQQ AAMDB AAMVS AAOGV AAPNW AAPQZ AAPXW AARHZ AAUAY AAUQX AAVAP AAWTL AAYXX ABDFA ABEJV ABEUO ABGNP ABIVO ABIXL ABJNI ABKDP ABLJU ABNCP ABNHQ ABNKS ABOCM ABPPZ ABPQP ABPTD ABQLI ABQNK ABSMQ ABUWG ABVGC ABVOZ ABWST ABXVV ABZBJ ACFRR ACGFO ACGFS ACGOD ACHQT ACNCT ACPQG ACUFI ACUTJ ACUTO ACVCV ACYHN ADBBV ADCFL ADEYI ADEZT ADGZP ADHKW ADHZD ADIPN ADNBA ADOCK ADQBN ADRTK ADVEK ADYVW ADZXQ AEGPL AEGXH AEHFB AEHKS AEJOX AEKSI AEMDU AEMQT AENEX AENZO AEPUE AETBJ AETEA AEWNT AFFNX AFFZL AFIYH AFKRA AFOFC AFXAL AGINJ AGKEF AGMDO AGORE AGQXC AGSYK AGUTN AHGBF AHMBA AHMMS AHXPO AIAGR AIJHB AJBYB AJEEA AJNCP AKWXX ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX AOIJS APIBT APJGH APWMN AQKUS ATGXG AWKKM AXUDD AZQEC AZXWR BAWUL BAYMD BCRHZ BENPR BEYMZ BHONS BTRTY BVRKM BZKNY C45 CAG CCPQU CDBKE CGNQK CITATION COF CS3 CZ4 DAKXR DIK DILTD DU5 DWQXO D~K E3Z EBD EBS EE~ EJD EMOBN ENERS EPA F5P F9B FA8 FECEO FLUFQ FOEOM FOTVD FQBLK FTD FYUFA GAUVT GJXCC GNUQQ GX1 H13 H5~ HAR HVGLF HW0 HYE HZ~ H~9 IOX ISO J21 JXSIZ KBUDW KOP KSI KSN M-Z M2M MBLQV MHKGH N4W N9A NAPCQ NGC NOMLY NOYVH NTWIH NU- O0~ O9- OAUYM OAWHX OCZFY ODMLO OJQWA OJZSN OK1 OPA OPAEJ OVD OWPYF O~Y P2P PAFKI PEELM PHGZM PHGZT PQQKQ PSYQQ Q1. Q5Y R44 RD5 RNI ROL ROX ROZ RPM RUSNO RW1 RXO RZF SPA SV3 TEORI TJX TN5 TR2 TWZ UKHRP ULE W8F WH7 WOQ X7H XJT XOL YAYTL YKOAZ YNT YR5 YROCO YXANX YYQ YZZ ZGI ZKX ZPI ~91 ABQTQ CGR CUY CVF ECM EIF M49 NPM 7X8 AAFWJ 7TK 5PM |
ID | FETCH-LOGICAL-c447t-e840a806a3ab7b923642c1403eac15345257b0309e21ebadce92e19896be091d3 |
ISSN | 0586-7614 1745-1701 |
IngestDate | Thu Aug 21 18:27:11 EDT 2025 Fri Jul 11 05:33:12 EDT 2025 Sun Sep 28 09:13:50 EDT 2025 Thu Apr 03 07:07:53 EDT 2025 Tue Jul 01 02:40:41 EDT 2025 Thu Apr 24 23:04:59 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | myelin NAC perineuronal net parvalbumin oligodendrocyte GABA oxidative stress |
Language | English |
License | The Author 2015. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c447t-e840a806a3ab7b923642c1403eac15345257b0309e21ebadce92e19896be091d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
PMID | 26032508 |
PQID | 1689623548 |
PQPubID | 23479 |
PageCount | 12 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4466197 proquest_miscellaneous_1717494966 proquest_miscellaneous_1689623548 pubmed_primary_26032508 crossref_citationtrail_10_1093_schbul_sbv065 crossref_primary_10_1093_schbul_sbv065 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-07-01 |
PublicationDateYYYYMMDD | 2015-07-01 |
PublicationDate_xml | – month: 07 year: 2015 text: 2015-07-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: US |
PublicationTitle | Schizophrenia bulletin |
PublicationTitleAlternate | Schizophr Bull |
PublicationYear | 2015 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | 2015062909134627000_41.4.835.24 2015062909134627000_41.4.835.23 2015062909134627000_41.4.835.26 2015062909134627000_41.4.835.25 2015062909134627000_41.4.835.28 2015062909134627000_41.4.835.27 2015062909134627000_41.4.835.29 Rabinovic (2015062909134627000_41.4.835.98) 1998; 71 2015062909134627000_41.4.835.108 2015062909134627000_41.4.835.109 2015062909134627000_41.4.835.106 2015062909134627000_41.4.835.107 Morishita (2015062909134627000_41.4.835.88) 2015062909134627000_41.4.835.104 2015062909134627000_41.4.835.105 2015062909134627000_41.4.835.102 2015062909134627000_41.4.835.103 2015062909134627000_41.4.835.20 2015062909134627000_41.4.835.100 2015062909134627000_41.4.835.101 2015062909134627000_41.4.835.22 2015062909134627000_41.4.835.21 2015062909134627000_41.4.835.35 2015062909134627000_41.4.835.34 2015062909134627000_41.4.835.37 2015062909134627000_41.4.835.36 2015062909134627000_41.4.835.39 2015062909134627000_41.4.835.38 Monin (2015062909134627000_41.4.835.114) 2014 2015062909134627000_41.4.835.119 Parnas (2015062909134627000_41.4.835.3) 2002; 1 2015062909134627000_41.4.835.117 2015062909134627000_41.4.835.118 2015062909134627000_41.4.835.116 2015062909134627000_41.4.835.113 2015062909134627000_41.4.835.31 2015062909134627000_41.4.835.111 2015062909134627000_41.4.835.30 2015062909134627000_41.4.835.112 2015062909134627000_41.4.835.33 2015062909134627000_41.4.835.32 2015062909134627000_41.4.835.89 Vostrikov (2015062909134627000_41.4.835.67) 2011; 2011 2015062909134627000_41.4.835.80 2015062909134627000_41.4.835.82 2015062909134627000_41.4.835.81 2015062909134627000_41.4.835.84 2015062909134627000_41.4.835.83 2015062909134627000_41.4.835.86 2015062909134627000_41.4.835.85 2015062909134627000_41.4.835.164 2015062909134627000_41.4.835.87 2015062909134627000_41.4.835.165 2015062909134627000_41.4.835.13 2015062909134627000_41.4.835.9 2015062909134627000_41.4.835.12 2015062909134627000_41.4.835.8 2015062909134627000_41.4.835.15 2015062909134627000_41.4.835.14 2015062909134627000_41.4.835.17 2015062909134627000_41.4.835.16 2015062909134627000_41.4.835.19 2015062909134627000_41.4.835.18 2015062909134627000_41.4.835.1 2015062909134627000_41.4.835.6 2015062909134627000_41.4.835.5 Noble (2015062909134627000_41.4.835.115) 2003; 991 2015062909134627000_41.4.835.4 2015062909134627000_41.4.835.91 2015062909134627000_41.4.835.90 2015062909134627000_41.4.835.93 2015062909134627000_41.4.835.92 2015062909134627000_41.4.835.95 2015062909134627000_41.4.835.97 2015062909134627000_41.4.835.96 2015062909134627000_41.4.835.11 2015062909134627000_41.4.835.99 2015062909134627000_41.4.835.10 2015062909134627000_41.4.835.68 2015062909134627000_41.4.835.151 2015062909134627000_41.4.835.152 2015062909134627000_41.4.835.69 2015062909134627000_41.4.835.150 Gross (2015062909134627000_41.4.835.2) 1987 2015062909134627000_41.4.835.60 2015062909134627000_41.4.835.148 2015062909134627000_41.4.835.149 2015062909134627000_41.4.835.146 2015062909134627000_41.4.835.61 2015062909134627000_41.4.835.147 2015062909134627000_41.4.835.64 2015062909134627000_41.4.835.144 2015062909134627000_41.4.835.63 2015062909134627000_41.4.835.145 2015062909134627000_41.4.835.66 2015062909134627000_41.4.835.142 2015062909134627000_41.4.835.65 2015062909134627000_41.4.835.143 2015062909134627000_41.4.835.79 2015062909134627000_41.4.835.162 2015062909134627000_41.4.835.78 2015062909134627000_41.4.835.163 2015062909134627000_41.4.835.160 2015062909134627000_41.4.835.161 Crabtree (2015062909134627000_41.4.835.7) 2014; 6 2015062909134627000_41.4.835.71 2015062909134627000_41.4.835.159 2015062909134627000_41.4.835.70 2015062909134627000_41.4.835.73 2015062909134627000_41.4.835.157 2015062909134627000_41.4.835.72 2015062909134627000_41.4.835.158 2015062909134627000_41.4.835.75 2015062909134627000_41.4.835.155 2015062909134627000_41.4.835.74 2015062909134627000_41.4.835.156 2015062909134627000_41.4.835.77 2015062909134627000_41.4.835.153 Uranova (2015062909134627000_41.4.835.62) 2011; 2011 2015062909134627000_41.4.835.76 2015062909134627000_41.4.835.154 2015062909134627000_41.4.835.46 2015062909134627000_41.4.835.45 2015062909134627000_41.4.835.130 2015062909134627000_41.4.835.48 2015062909134627000_41.4.835.47 2015062909134627000_41.4.835.49 Steullet (2015062909134627000_41.4.835.94) 2011 2015062909134627000_41.4.835.128 2015062909134627000_41.4.835.129 2015062909134627000_41.4.835.126 2015062909134627000_41.4.835.127 2015062909134627000_41.4.835.40 2015062909134627000_41.4.835.124 2015062909134627000_41.4.835.42 2015062909134627000_41.4.835.122 2015062909134627000_41.4.835.41 2015062909134627000_41.4.835.123 2015062909134627000_41.4.835.44 2015062909134627000_41.4.835.120 2015062909134627000_41.4.835.43 2015062909134627000_41.4.835.121 2015062909134627000_41.4.835.57 2015062909134627000_41.4.835.140 2015062909134627000_41.4.835.56 2015062909134627000_41.4.835.141 2015062909134627000_41.4.835.59 2015062909134627000_41.4.835.58 2015062909134627000_41.4.835.139 El Waly (2015062909134627000_41.4.835.110) 2014; 8 2015062909134627000_41.4.835.137 2015062909134627000_41.4.835.138 2015062909134627000_41.4.835.51 2015062909134627000_41.4.835.135 2015062909134627000_41.4.835.50 2015062909134627000_41.4.835.136 2015062909134627000_41.4.835.53 2015062909134627000_41.4.835.133 2015062909134627000_41.4.835.52 Steullet (2015062909134627000_41.4.835.125) 2014 2015062909134627000_41.4.835.134 2015062909134627000_41.4.835.55 2015062909134627000_41.4.835.131 2015062909134627000_41.4.835.54 2015062909134627000_41.4.835.132 21969553 - Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):E962-70 25000913 - Schizophr Res. 2016 Sep;176(1):41-51 21872380 - Brain Cogn. 2011 Nov;77(2):248-56 12742865 - Arch Gen Psychiatry. 2003 May;60(5):443-56 22383949 - PLoS One. 2012;7(2):e29341 11115327 - Arch Gen Psychiatry. 2000 Dec;57(12):1139-47 23369637 - Trends Pharmacol Sci. 2013 Mar;34(3):167-77 24316471 - Neuroscience. 2014 Feb 14;259:223-31 16730162 - Schizophr Res. 2006 Jul;85(1-3):245-53 23446060 - Dev Neurosci. 2013;35(2-3):102-29 23192314 - Psychopharmacology (Berl). 2013 Apr;226(3):531-40 12372654 - Biol Psychiatry. 2002 Oct 15;52(8):823-30 22981772 - Curr Biol. 2012 Oct 23;22(20):1914-7 20080054 - Trends Cogn Sci. 2010 Feb;14(2):72-80 21645555 - Behav Brain Res. 2011 Oct 10;224(1):15-22 21126177 - Antioxid Redox Signal. 2011 Oct 1;15(7):2011-35 25126763 - Harv Rev Psychiatry. 2014 Sep-Oct;22(5):251-65 20505089 - J Neurosci. 2010 May 26;30(21):7227-35 23324948 - Curr Opin Psychiatry. 2013 Mar;26(2):172-87 20955757 - Prog Neurobiol. 2011 Jan;93(1):23-58 18436195 - Biol Psychiatry. 2008 Sep 1;64(5):361-8 20080551 - Proc Natl Acad Sci U S A. 2010 Jan 19;107(3):1211-6 22246436 - Nat Neurosci. 2012 Mar;15(3):414-22, S1-2 23671099 - Proc Natl Acad Sci U S A. 2013 May 28;110(22):9130-5 24000072 - Metab Brain Dis. 2013 Dec;28(4):687-96 24336286 - Nature. 2013 Dec 12;504(7479):272-6 25320232 - Sci Transl Med. 2014 Oct 15;6(258):258ra140 21068826 - Nature. 2010 Nov 11;468(7321):187-93 25128179 - Neurology. 2014 Sep 16;83(12):1112-8 20124114 - Arch Gen Psychiatry. 2010 Feb;67(2):146-54 12462417 - Neurochem Res. 2002 Oct;27(10):1193-200 22243754 - Neuron. 2012 Jan 12;73(1):159-70 19805354 - Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16663-8 9517569 - Glia. 1998 Apr;22(4):371-8 21468034 - Mol Psychiatry. 2012 May;17(5):537-48 18291369 - Exp Neurol. 2008 Apr;210(2):560-76 17180162 - Nat Rev Neurosci. 2007 Jan;8(1):45-56 13678875 - Lancet. 2003 Sep 6;362(9386):798-805 24888524 - Schizophr Res. 2014 Aug;157(1-3):238-43 16043134 - Biol Psychiatry. 2005 Dec 15;58(12):921-9 24896567 - J Cereb Blood Flow Metab. 2014 Aug;34(8):1270-82 21129940 - Exp Toxicol Pathol. 2012 Jul;64(5):503-8 21068319 - J Neurosci. 2010 Nov 10;30(45):15134-45 16410648 - Dis Markers. 2006;22(1-2):83-93 11296301 - Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4746-51 16420437 - Eur J Neurosci. 2006 Jan;23(1):279-84 20388854 - Clin Cancer Res. 2010 May 1;16(9):2580-90 18063801 - Science. 2007 Dec 7;318(5856):1645-7 20463017 - J Biol Chem. 2010 Jul 16;285(29):22244-53 19036962 - J Neurosci. 2008 Nov 26;28(48):12691-9 17956979 - Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17500-5 11955958 - Schizophr Res. 2002 May 1;55(1-2):1-10 25758057 - Biol Psychiatry. 2015 Sep 15;78(6):396-402 21546001 - Biol Psychiatry. 2011 Jul 1;70(1):97-105 17296559 - Neuron. 2007 Feb 15;53(4):591-604 17566708 - Schizophr Res. 2007 Aug;94(1-3):273-80 19396156 - Nature. 2009 Jun 4;459(7247):663-7 25132466 - Neuron. 2014 Sep 3;83(5):1073-84 22938092 - Antioxid Redox Signal. 2013 Apr 20;18(12):1428-43 21716263 - Neuropsychopharmacology. 2011 Oct;36(11):2233-43 19559404 - Biol Psychiatry. 2009 Aug 15;66(4):384-92 23317110 - J Neuroimaging. 2014 Mar-Apr;24(2):101-10 24285906 - J Neurosci. 2013 Nov 27;33(48):19023-33 10880854 - Prog Neurobiol. 2000 Dec;62(6):649-71 23790226 - Biol Psychiatry. 2013 Sep 15;74(6):427-35 20964735 - J Intern Med. 2010 Nov;268(5):432-48 22154068 - Trends Neurosci. 2012 Jan;35(1):57-67 12660804 - Mol Psychiatry. 2003 Mar;8(3):316-23, 251 22033334 - Behav Brain Res. 2012 Jan 15;226(2):563-70 24270424 - J Clin Invest. 2013 Dec;123(12):5389-400 17194275 - J Clin Psychiatry. 2006 Dec;67(12):1954-67 23045690 - Proc Natl Acad Sci U S A. 2012 Oct 16;109 Suppl 2:17213-20 25155877 - Mol Psychiatry. 2015 Jul;20(7):827-38 24080972 - Dev Neurosci. 2013;35(5):427-36 17594127 - J Neural Transm (Vienna). 2007 Jul;114(7):893-8 23946395 - J Neurosci. 2013 Aug 14;33(33):13375-87 21071629 - Science. 2010 Nov 26;330(6008):1238-40 16481179 - Neurobiol Dis. 2006 Jun;22(3):624-37 21703648 - Neuropharmacology. 2012 Mar;62(3):1273-89 20550570 - Eur J Neurosci. 2010 Jun;31(12):2185-92 6430187 - Ann N Y Acad Sci. 1984;429:494-7 25189204 - Neuron. 2014 Sep 3;83(5):991-3 16213148 - Neurobiol Dis. 2006 Mar;21(3):531-40 23430731 - Clin Psychopharmacol Neurosci. 2012 Aug;10(2):94-8 21679927 - Biol Psychiatry. 2011 Sep 1;70(5):434-40 14984887 - Schizophr Res. 2004 Apr 1;67(2-3):269-75 20124115 - Arch Gen Psychiatry. 2010 Feb;67(2):155-66 23770240 - Cell Rep. 2013 Jun 27;3(6):1815-23 22958818 - Neuron. 2012 Sep 6;75(5):762-77 22937261 - Schizophr Res Treatment. 2011;2011:174689 25164659 - J Neurosci. 2014 Aug 27;34(35):11631-40 17555828 - Trends Neurosci. 2007 Jul;30(7):309-16 14720201 - J Neurochem. 2004 Feb;88(3):513-31 24971048 - Front Neurosci. 2014 Jun 12;8:145 21923690 - Fundam Clin Pharmacol. 2012 Dec;26(6):712-21 17675407 - Proc Natl Acad Sci U S A. 2007 Sep 4;104(36):14501-6 22998866 - Neuron. 2012 Sep 20;75(6):963-80 19735056 - World J Biol Psychiatry. 2009;10(4 Pt 2):626-8 20087360 - Nat Rev Neurosci. 2010 Feb;11(2):100-13 9822384 - Science. 1998 Nov 20;282(5393):1504-8 21505115 - Schizophr Bull. 2011 May;37(3):484-92 18391126 - Arch Gen Psychiatry. 2008 Apr;65(4):378-85 16571750 - J Neurosci. 2006 Mar 29;26(13):3434-43 14973232 - J Neurosci. 2004 Feb 18;24(7):1531-40 18524546 - Eur Psychiatry. 2008 Jun;23(4):255-73 22956832 - J Neurosci. 2012 Sep 5;32(36):12411-20 21183487 - Brain. 2011 Feb;134(Pt 2):345-58 20633320 - Int J Neuropsychopharmacol. 2011 Feb;14(1):123-30 25505409 - Front Synaptic Neurosci. 2014 Nov 25;6:28 22277333 - Biol Psychiatry. 2012 Mar 15;71(6):503-11 22406547 - Nat Neurosci. 2012 May;15(5):703-12 16261181 - Nat Rev Neurosci. 2005 Nov;6(11):877-88 12846992 - Ann N Y Acad Sci. 2003 Jun;991:251-71 16946833 - World Psychiatry. 2002 Oct;1(3):131-6 24201233 - Clin Neuropharmacol. 2013 Nov-Dec;36(6):185-92 18004285 - Neuropsychopharmacology. 2008 Aug;33(9):2187-99 18023140 - Brain Behav Immun. 2008 May;22(4):469-86 19847447 - Acta Neuropathol. 2010 Jan;119(1):37-53 23140664 - Biol Psychiatry. 2013 Mar 15;73(6):574-82 22910687 - Psychoneuroendocrinology. 2013 Apr;38(4):509-21 22937264 - Schizophr Res Treatment. 2011;2011:325789 19396159 - Nature. 2009 Jun 4;459(7247):698-702 24309249 - Prog Brain Res. 2013;207:3-34 22364738 - Biol Psychiatry. 2012 Mar 15;71(6):512-20 23612434 - Neuropsychopharmacology. 2013 Sep;38(10):1881-8 21801840 - Neuroimage. 2011 Oct 15;58(4):1081-9 23400808 - Curr Psychiatry Rep. 2013 Mar;15(3):346 17298174 - PLoS Biol. 2007 Feb;5(2):e35 18395805 - Trends Neurosci. 2008 May;31(5):234-42 22764251 - J Neurosci. 2012 Jul 4;32(27):9429-37 12670706 - Brain Res Mol Brain Res. 2003 Apr 10;112(1-2):90-4 20393464 - Nature. 2010 Apr 29;464(7293):1376-80 11029642 - Eur J Neurosci. 2000 Oct;12(10):3721-8 21040854 - Neuron. 2010 Nov 4;68(3):557-69 20164340 - J Neurosci. 2010 Feb 17;30(7):2547-58 21945305 - Biol Psychiatry. 2012 Jun 1;71(11):1006-14 9542724 - Neurochem Int. 1998 Feb;32(2):117-31 24787547 - Int J Neuropsychopharmacol. 2014 Oct;17(10):1609-19 18988857 - Science. 2008 Nov 7;322(5903):967-70 19204281 - Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3561-6 12513945 - Biol Psychiatry. 2003 Jan 1;53(1):56-64 20950668 - Prog Neurobiol. 2011 Jan;93(1):13-24 25801703 - Neuron. 2015 Apr 8;86(1):264-75 21068299 - J Neurosci. 2010 Nov 10;30(45):14964-71 12032331 - Proc Natl Acad Sci U S A. 2002 May 28;99(11):7610-5 9798932 - J Neurochem. 1998 Nov;71(5):2071-8 22640876 - Neuroscience. 2012 Apr 19;208:58-68 14690769 - J Psychiatr Res. 2004 Jan;38(1):37-46 24348349 - Front Syst Neurosci. 2013 Dec 03;7:102 18684987 - Am J Physiol Cell Physiol. 2008 Oct;295(4):C849-68 23152631 - J Neurosci. 2012 Nov 14;32(46):16496-502 12603840 - J Neurochem. 2003 Mar;84(5):1173-83 19244511 - J Neurosci. 2009 Feb 25;29(8):2344-54 20855415 - Schizophr Bull. 2012 May;38(3):486-94 24488531 - J Mol Neurosci. 2014 Aug;53(4):654-60 18322470 - Neuropsychopharmacology. 2008 Nov;33(12):2993-3009 21571254 - Biol Psychiatry. 2011 Jul 1;70(1):19-27 19631237 - Behav Brain Res. 2009 Dec 28;205(2):355-9 8830852 - Neurosci Lett. 1996 Jun 21;211(2):93-6 21968533 - Acta Neuropathol. 2011 Nov;122(5):615-26 |
References_xml | – ident: 2015062909134627000_41.4.835.41 doi: 10.1523/JNEUROSCI.1666-13.2013 – ident: 2015062909134627000_41.4.835.61 doi: 10.1016/j.pneurobio.2010.09.004 – ident: 2015062909134627000_41.4.835.105 doi: 10.1046/j.1471-4159.2003.02211.x – ident: 2015062909134627000_41.4.835.42 doi: 10.1038/mp.2011.31 – ident: 2015062909134627000_41.4.835.47 doi: 10.1016/j.pneurobio.2010.09.003 – ident: 2015062909134627000_41.4.835.100 doi: 10.1038/nn.3023 – ident: 2015062909134627000_41.4.835.28 doi: 10.3389/fnsys.2013.00102 – ident: 2015062909134627000_41.4.835.74 doi: 10.1016/j.biopsych.2005.05.015 – ident: 2015062909134627000_41.4.835.60 doi: 10.1001/archpsyc.60.5.443 – ident: 2015062909134627000_41.4.835.121 doi: 10.1016/j.biopsych.2012.01.013 – ident: 2015062909134627000_41.4.835.144 doi: 10.1016/j.tips.2013.01.001 – ident: 2015062909134627000_41.4.835.58 doi: 10.1523/JNEUROSCI.4166-08.2008 – ident: 2015062909134627000_41.4.835.46 doi: 10.1073/pnas.0910302107 – ident: 2015062909134627000_41.4.835.31 doi: 10.1007/s00401-011-0881-4 – ident: 2015062909134627000_41.4.835.56 doi: 10.1016/j.biopsych.2009.04.033 – ident: 2015062909134627000_41.4.835.22 doi: 10.1038/nn.3070 – ident: 2015062909134627000_41.4.835.8 doi: 10.1016/B978-0-444-63327-9.00001-1 – ident: 2015062909134627000_41.4.835.88 article-title: Prolonged period of cortical plasticity upon redox dysregulation in fast-spiking interneurons publication-title: Biol Psychiatry – ident: 2015062909134627000_41.4.835.117 doi: 10.1371/journal.pbio.0050035 – ident: 2015062909134627000_41.4.835.15 doi: 10.1523/JNEUROSCI.4104-10.2010 – ident: 2015062909134627000_41.4.835.90 doi: 10.1523/JNEUROSCI.0698-10.2010 – ident: 2015062909134627000_41.4.835.131 doi: 10.1016/j.biopsych.2011.02.011 – volume: 8 start-page: 145 year: 2014 ident: 2015062909134627000_41.4.835.110 article-title: Oligodendrogenesis in the normal and pathological central nervous system publication-title: Front Neurosci doi: 10.3389/fnins.2014.00145 – volume: 6 start-page: 28 year: 2014 ident: 2015062909134627000_41.4.835.7 article-title: Synaptic plasticity, neural circuits, and the emerging role of altered short-term information processing in schizophrenia publication-title: Front Synaptic Neurosci doi: 10.3389/fnsyn.2014.00028 – ident: 2015062909134627000_41.4.835.139 doi: 10.1073/pnas.0908908106 – ident: 2015062909134627000_41.4.835.75 doi: 10.1016/j.eurpsy.2007.12.004 – ident: 2015062909134627000_41.4.835.140 doi: 10.1158/1078-0432.CCR-09-2937 – ident: 2015062909134627000_41.4.835.163 doi: 10.1016/j.celrep.2013.05.014 – ident: 2015062909134627000_41.4.835.14 doi: 10.1016/j.neuron.2007.01.031 – ident: 2015062909134627000_41.4.835.146 doi: 10.1016/j.biopsych.2011.07.035 – ident: 2015062909134627000_41.4.835.124 doi: 10.1016/j.cub.2012.08.012 – volume: 1 start-page: 131 year: 2002 ident: 2015062909134627000_41.4.835.3 article-title: Schizophrenic autism: clinical phenomenology and pathogenetic implications publication-title: World Psychiatry – ident: 2015062909134627000_41.4.835.120 doi: 10.1016/j.biopsych.2011.02.031 – ident: 2015062909134627000_41.4.835.63 doi: 10.1016/j.schres.2006.03.029 – ident: 2015062909134627000_41.4.835.103 doi: 10.1016/j.neuron.2014.07.028 – ident: 2015062909134627000_41.4.835.104 doi: 10.1111/j.1460-9568.2005.04536.x – ident: 2015062909134627000_41.4.835.16 doi: 10.1523/JNEUROSCI.3475-12.2012 – ident: 2015062909134627000_41.4.835.152 doi: 10.1016/j.biopsych.2008.03.004 – ident: 2015062909134627000_41.4.835.49 doi: 10.1016/j.bbr.2009.07.014 – ident: 2015062909134627000_41.4.835.157 doi: 10.1371/journal.pone.0029341 – ident: 2015062909134627000_41.4.835.43 doi: 10.1073/pnas.1109625108 – ident: 2015062909134627000_41.4.835.164 doi: 10.1016/j.bandc.2011.08.003 – ident: 2015062909134627000_41.4.835.39 doi: 10.1016/j.neuron.2011.12.013 – ident: 2015062909134627000_41.4.835.33 doi: 10.1016/j.tins.2011.10.004 – ident: 2015062909134627000_41.4.835.54 doi: 10.1016/j.biopsych.2011.05.006 – volume: 71 start-page: 2071 year: 1998 ident: 2015062909134627000_41.4.835.98 article-title: Role of endogenous glutathione in the oxidation of dopamine publication-title: J Neurochem doi: 10.1046/j.1471-4159.1998.71052071.x – ident: 2015062909134627000_41.4.835.113 doi: 10.1002/(SICI)1098-1136(199804)22:4<371::AID-GLIA6>3.0.CO;2-6 – ident: 2015062909134627000_41.4.835.134 doi: 10.1016/j.neuroscience.2013.11.049 – ident: 2015062909134627000_41.4.835.161 doi: 10.1111/j.1460-9568.2010.07261.x – ident: 2015062909134627000_41.4.835.44 doi: 10.1038/nature08928 – ident: 2015062909134627000_41.4.835.102 doi: 10.1016/j.neuron.2015.02.036 – ident: 2015062909134627000_41.4.835.9 doi: 10.1038/nrn1787 – ident: 2015062909134627000_41.4.835.91 doi: 10.1126/science.1148045 – ident: 2015062909134627000_41.4.835.27 doi: 10.1073/pnas.1200705109 – ident: 2015062909134627000_41.4.835.23 doi: 10.1126/science.1161151 – ident: 2015062909134627000_41.4.835.76 doi: 10.1111/j.1552-6569.2012.00779.x – ident: 2015062909134627000_41.4.835.50 doi: 10.1016/j.bbi.2007.09.012 – ident: 2015062909134627000_41.4.835.109 doi: 10.1111/j.1749-6632.1984.tb12376.x – ident: 2015062909134627000_41.4.835.112 doi: 10.1523/JNEUROSCI.3989-03.2004 – ident: 2015062909134627000_41.4.835.6 doi: 10.1016/S0022-3956(03)00095-5 – ident: 2015062909134627000_41.4.835.21 doi: 10.1523/JNEUROSCI.4812-10.2010 – ident: 2015062909134627000_41.4.835.25 doi: 10.1126/science.1195320 – ident: 2015062909134627000_41.4.835.85 doi: 10.1016/j.biopsych.2012.09.020 – ident: 2015062909134627000_41.4.835.78 doi: 10.1111/j.1365-2796.2010.02268.x – ident: 2015062909134627000_41.4.835.66 doi: 10.1016/j.schres.2007.04.014 – ident: 2015062909134627000_41.4.835.111 doi: 10.1016/S0301-0082(99)00060-X – ident: 2015062909134627000_41.4.835.141 doi: 10.1016/j.etp.2010.11.005 – ident: 2015062909134627000_41.4.835.45 doi: 10.1073/pnas.0704774104 – ident: 2015062909134627000_41.4.835.36 doi: 10.1007/s11920-012-0346-z – ident: 2015062909134627000_41.4.835.165 doi: 10.1016/j.neuron.2014.08.028 – ident: 2015062909134627000_41.4.835.95 doi: 10.1016/j.bbr.2011.10.020 – ident: 2015062909134627000_41.4.835.10 doi: 10.1523/JNEUROSCI.4076-05.2006 – ident: 2015062909134627000_41.4.835.32 doi: 10.1016/S0920-9964(01)00188-8 – ident: 2015062909134627000_41.4.835.53 doi: 10.1159/000354178 – volume-title: Bonner Skala für die Beurteilung von Basissymptomen year: 1987 ident: 2015062909134627000_41.4.835.2 – ident: 2015062909134627000_41.4.835.72 doi: 10.1093/schbul/sbq105 – ident: 2015062909134627000_41.4.835.92 doi: 10.1016/j.nbd.2006.01.003 – ident: 2015062909134627000_41.4.835.73 doi: 10.1097/YCO.0b013e32835d9e6a – ident: 2015062909134627000_41.4.835.65 doi: 10.1016/S0920-9964(03)00181-6 – ident: 2015062909134627000_41.4.835.68 doi: 10.1016/j.nbd.2005.08.012 – ident: 2015062909134627000_41.4.835.147 doi: 10.1016/j.expneurol.2007.12.011 – volume: 2011 start-page: 174689 year: 2011 ident: 2015062909134627000_41.4.835.67 article-title: Age-related increase in the number of oligodendrocytes is dysregulated in schizophrenia and mood disorders publication-title: Schizophr Res Treatment doi: 10.1155/2011/174689 – ident: 2015062909134627000_41.4.835.38 doi: 10.1016/j.neuron.2012.09.004 – ident: 2015062909134627000_41.4.835.162 doi: 10.1523/JNEUROSCI.0545-14.2014 – ident: 2015062909134627000_41.4.835.133 doi: 10.1007/s12031-014-0232-8 – ident: 2015062909134627000_41.4.835.107 doi: 10.1017/S146114571400056X – ident: 2015062909134627000_41.4.835.82 doi: 10.1046/j.1460-9568.2000.00229.x – start-page: 149 volume-title: Animal Models of Schizophrenia and Related Disorders year: 2011 ident: 2015062909134627000_41.4.835.94 article-title: Glutathione deficit in animal models of schizophrenia doi: 10.1007/978-1-61779-157-4_7 – ident: 2015062909134627000_41.4.835.59 doi: 10.1159/000346157 – ident: 2015062909134627000_41.4.835.69 doi: 10.1073/pnas.081071198 – ident: 2015062909134627000_41.4.835.158 doi: 10.1046/j.1471-4159.2003.01580.x – ident: 2015062909134627000_41.4.835.119 doi: 10.1001/archpsyc.65.4.378 – ident: 2015062909134627000_41.4.835.126 doi: 10.1016/j.neuropharm.2011.04.019 – ident: 2015062909134627000_41.4.835.148 – ident: 2015062909134627000_41.4.835.96 doi: 10.1016/j.neuroimage.2011.07.030 – ident: 2015062909134627000_41.4.835.99 doi: 10.1523/JNEUROSCI.0394-12.2012 – ident: 2015062909134627000_41.4.835.48 doi: 10.1016/j.psyneuen.2012.07.011 – ident: 2015062909134627000_41.4.835.128 doi: 10.1016/S0006-3223(02)01397-5 – ident: 2015062909134627000_41.4.835.150 doi: 10.1038/npp.2011.109 – ident: 2015062909134627000_41.4.835.159 doi: 10.1038/npp.2013.101 – ident: 2015062909134627000_41.4.835.138 doi: 10.1073/pnas.0708710104 – ident: 2015062909134627000_41.4.835.155 doi: 10.1038/sj.npp.1301624 – ident: 2015062909134627000_41.4.835.19 doi: 10.1073/pnas.0813176106 – volume: 2011 start-page: 325789 year: 2011 ident: 2015062909134627000_41.4.835.62 article-title: Ultrastructural alterations of myelinated fibers and oligodendrocytes in the prefrontal cortex in schizophrenia: a postmortem morphometric study publication-title: Schizophr Res Treatment doi: 10.1155/2011/325789 – ident: 2015062909134627000_41.4.835.13 doi: 10.1038/nature08002 – ident: 2015062909134627000_41.4.835.97 doi: 10.1016/S0197-0186(97)00031-4 – ident: 2015062909134627000_41.4.835.20 doi: 10.1016/j.tics.2009.12.002 – ident: 2015062909134627000_41.4.835.34 doi: 10.1016/j.biopsych.2013.05.007 – ident: 2015062909134627000_41.4.835.51 doi: 10.1016/0304-3940(96)12733-6 – ident: 2015062909134627000_41.4.835.101 doi: 10.1172/JCI70317 – ident: 2015062909134627000_41.4.835.11 doi: 10.1038/nrn2044 – year: 2014 ident: 2015062909134627000_41.4.835.125 article-title: Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: a “central hub” in schizophrenia pathophysiology? publication-title: Schizophr Res doi: 10.1016/j.schres.2014.06.021 – ident: 2015062909134627000_41.4.835.156 doi: 10.1001/archpsyc.57.12.1139 – ident: 2015062909134627000_41.4.835.5 doi: 10.1212/WNL.0000000000000798 – ident: 2015062909134627000_41.4.835.12 doi: 10.1016/j.tins.2007.05.005 – ident: 2015062909134627000_41.4.835.37 doi: 10.1038/nrn2774 – ident: 2015062909134627000_41.4.835.84 doi: 10.1155/2006/248387 – ident: 2015062909134627000_41.4.835.127 doi: 10.1089/ars.2010.3603 – ident: 2015062909134627000_41.4.835.83 doi: 10.1017/S1461145710000805 – ident: 2015062909134627000_41.4.835.87 doi: 10.1523/JNEUROSCI.3857-09.2010 – ident: 2015062909134627000_41.4.835.143 doi: 10.9758/cpn.2012.10.2.94 – ident: 2015062909134627000_41.4.835.17 doi: 10.1038/nature07991 – ident: 2015062909134627000_41.4.835.29 doi: 10.1016/j.tins.2008.02.005 – ident: 2015062909134627000_41.4.835.136 doi: 10.1001/archgenpsychiatry.2009.192 – ident: 2015062909134627000_41.4.835.118 doi: 10.1016/S0169-328X(03)00051-2 – ident: 2015062909134627000_41.4.835.4 doi: 10.1097/HRP.0000000000000040 – ident: 2015062909134627000_41.4.835.93 doi: 10.1089/ars.2012.4858 – ident: 2015062909134627000_41.4.835.123 doi: 10.1016/j.bbr.2011.05.017 – ident: 2015062909134627000_41.4.835.116 doi: 10.1016/j.biopsych.2013.11.017 – ident: 2015062909134627000_41.4.835.79 doi: 10.1093/brain/awq333 – ident: 2015062909134627000_41.4.835.18 doi: 10.1016/j.neuron.2010.09.017 – ident: 2015062909134627000_41.4.835.151 doi: 10.1007/s11011-013-9433-z – ident: 2015062909134627000_41.4.835.160 doi: 10.1126/science.282.5393.1504 – ident: 2015062909134627000_41.4.835.108 doi: 10.1007/s00401-009-0601-5 – ident: 2015062909134627000_41.4.835.145 doi: 10.1074/jbc.M110.121327 – ident: 2015062909134627000_41.4.835.81 doi: 10.1038/jcbfm.2014.104 – ident: 2015062909134627000_41.4.835.70 doi: 10.1016/S0140-6736(03)14289-4 – ident: 2015062909134627000_41.4.835.77 doi: 10.1152/ajpcell.00283.2008 – ident: 2015062909134627000_41.4.835.55 doi: 10.1007/s00702-007-0627-6 – ident: 2015062909134627000_41.4.835.64 doi: 10.1023/A:1020981510759 – ident: 2015062909134627000_41.4.835.106 doi: 10.1016/j.schres.2014.05.005 – ident: 2015062909134627000_41.4.835.40 doi: 10.1523/JNEUROSCI.0421-12.2012 – ident: 2015062909134627000_41.4.835.57 doi: 10.1523/JNEUROSCI.5419-08.2009 – ident: 2015062909134627000_41.4.835.89 doi: 10.1016/j.neuroscience.2012.02.017 – ident: 2015062909134627000_41.4.835.122 doi: 10.1016/j.biopsych.2011.12.016 – ident: 2015062909134627000_41.4.835.130 doi: 10.1016/0006-3223(93)90277-K – volume: 991 start-page: 251 year: 2003 ident: 2015062909134627000_41.4.835.115 article-title: Redox state as a central modulator of precursor cell function publication-title: Ann N Y Acad Sci doi: 10.1111/j.1749-6632.2003.tb07481.x – ident: 2015062909134627000_41.4.835.30 doi: 10.1093/schbul/sbr028 – ident: 2015062909134627000_41.4.835.149 doi: 10.1007/s00213-012-2926-3 – ident: 2015062909134627000_41.4.835.129 doi: 10.1038/sj.mp.4001325 – year: 2014 ident: 2015062909134627000_41.4.835.114 article-title: Glutathione deficit impairs myelin maturation: relevance for white matter integrity in schizophrenia patients publication-title: Mol Psychiatry – ident: 2015062909134627000_41.4.835.132 doi: 10.1016/S0006-3223(02)01443-9 – ident: 2015062909134627000_41.4.835.137 doi: 10.1073/pnas.112203099 – ident: 2015062909134627000_41.4.835.135 doi: 10.4088/JCP.v67n1217 – ident: 2015062909134627000_41.4.835.71 doi: 10.1038/npp.2008.19 – ident: 2015062909134627000_41.4.835.24 doi: 10.1126/scitranslmed.3010157 – ident: 2015062909134627000_41.4.835.35 doi: 10.1001/archgenpsychiatry.2009.196 – ident: 2015062909134627000_41.4.835.154 doi: 10.1097/WNF.0000000000000001 – ident: 2015062909134627000_41.4.835.80 doi: 10.1016/j.neuron.2012.08.019 – ident: 2015062909134627000_41.4.835.52 doi: 10.1523/JNEUROSCI.5286-12.2013 – ident: 2015062909134627000_41.4.835.153 doi: 10.1080/15622970903144004 – ident: 2015062909134627000_41.4.835.1 doi: 10.1038/nature09552 – ident: 2015062909134627000_41.4.835.26 doi: 10.1038/nature12866 – ident: 2015062909134627000_41.4.835.86 doi: 10.1073/pnas.1300454110 – ident: 2015062909134627000_41.4.835.142 doi: 10.1111/j.1472-8206.2011.00988.x – reference: 25164659 - J Neurosci. 2014 Aug 27;34(35):11631-40 – reference: 21872380 - Brain Cogn. 2011 Nov;77(2):248-56 – reference: 22277333 - Biol Psychiatry. 2012 Mar 15;71(6):503-11 – reference: 17594127 - J Neural Transm (Vienna). 2007 Jul;114(7):893-8 – reference: 16213148 - Neurobiol Dis. 2006 Mar;21(3):531-40 – reference: 13678875 - Lancet. 2003 Sep 6;362(9386):798-805 – reference: 14973232 - J Neurosci. 2004 Feb 18;24(7):1531-40 – reference: 20164340 - J Neurosci. 2010 Feb 17;30(7):2547-58 – reference: 22154068 - Trends Neurosci. 2012 Jan;35(1):57-67 – reference: 23045690 - Proc Natl Acad Sci U S A. 2012 Oct 16;109 Suppl 2:17213-20 – reference: 22937261 - Schizophr Res Treatment. 2011;2011:174689 – reference: 14690769 - J Psychiatr Res. 2004 Jan;38(1):37-46 – reference: 21468034 - Mol Psychiatry. 2012 May;17(5):537-48 – reference: 18524546 - Eur Psychiatry. 2008 Jun;23(4):255-73 – reference: 25000913 - Schizophr Res. 2016 Sep;176(1):41-51 – reference: 22938092 - Antioxid Redox Signal. 2013 Apr 20;18(12):1428-43 – reference: 21571254 - Biol Psychiatry. 2011 Jul 1;70(1):19-27 – reference: 23369637 - Trends Pharmacol Sci. 2013 Mar;34(3):167-77 – reference: 6430187 - Ann N Y Acad Sci. 1984;429:494-7 – reference: 16481179 - Neurobiol Dis. 2006 Jun;22(3):624-37 – reference: 22364738 - Biol Psychiatry. 2012 Mar 15;71(6):512-20 – reference: 21716263 - Neuropsychopharmacology. 2011 Oct;36(11):2233-43 – reference: 25132466 - Neuron. 2014 Sep 3;83(5):1073-84 – reference: 24080972 - Dev Neurosci. 2013;35(5):427-36 – reference: 21071629 - Science. 2010 Nov 26;330(6008):1238-40 – reference: 22981772 - Curr Biol. 2012 Oct 23;22(20):1914-7 – reference: 18391126 - Arch Gen Psychiatry. 2008 Apr;65(4):378-85 – reference: 9822384 - Science. 1998 Nov 20;282(5393):1504-8 – reference: 24316471 - Neuroscience. 2014 Feb 14;259:223-31 – reference: 12513945 - Biol Psychiatry. 2003 Jan 1;53(1):56-64 – reference: 18436195 - Biol Psychiatry. 2008 Sep 1;64(5):361-8 – reference: 20550570 - Eur J Neurosci. 2010 Jun;31(12):2185-92 – reference: 23946395 - J Neurosci. 2013 Aug 14;33(33):13375-87 – reference: 21505115 - Schizophr Bull. 2011 May;37(3):484-92 – reference: 23430731 - Clin Psychopharmacol Neurosci. 2012 Aug;10(2):94-8 – reference: 20955757 - Prog Neurobiol. 2011 Jan;93(1):23-58 – reference: 25801703 - Neuron. 2015 Apr 8;86(1):264-75 – reference: 17675407 - Proc Natl Acad Sci U S A. 2007 Sep 4;104(36):14501-6 – reference: 20393464 - Nature. 2010 Apr 29;464(7293):1376-80 – reference: 20124115 - Arch Gen Psychiatry. 2010 Feb;67(2):155-66 – reference: 17180162 - Nat Rev Neurosci. 2007 Jan;8(1):45-56 – reference: 23140664 - Biol Psychiatry. 2013 Mar 15;73(6):574-82 – reference: 24348349 - Front Syst Neurosci. 2013 Dec 03;7:102 – reference: 17956979 - Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17500-5 – reference: 22910687 - Psychoneuroendocrinology. 2013 Apr;38(4):509-21 – reference: 21068299 - J Neurosci. 2010 Nov 10;30(45):14964-71 – reference: 22033334 - Behav Brain Res. 2012 Jan 15;226(2):563-70 – reference: 25128179 - Neurology. 2014 Sep 16;83(12):1112-8 – reference: 10880854 - Prog Neurobiol. 2000 Dec;62(6):649-71 – reference: 20505089 - J Neurosci. 2010 May 26;30(21):7227-35 – reference: 11115327 - Arch Gen Psychiatry. 2000 Dec;57(12):1139-47 – reference: 24270424 - J Clin Invest. 2013 Dec;123(12):5389-400 – reference: 24896567 - J Cereb Blood Flow Metab. 2014 Aug;34(8):1270-82 – reference: 12660804 - Mol Psychiatry. 2003 Mar;8(3):316-23, 251 – reference: 22640876 - Neuroscience. 2012 Apr 19;208:58-68 – reference: 12670706 - Brain Res Mol Brain Res. 2003 Apr 10;112(1-2):90-4 – reference: 9542724 - Neurochem Int. 1998 Feb;32(2):117-31 – reference: 24888524 - Schizophr Res. 2014 Aug;157(1-3):238-43 – reference: 12603840 - J Neurochem. 2003 Mar;84(5):1173-83 – reference: 20964735 - J Intern Med. 2010 Nov;268(5):432-48 – reference: 11029642 - Eur J Neurosci. 2000 Oct;12(10):3721-8 – reference: 18023140 - Brain Behav Immun. 2008 May;22(4):469-86 – reference: 21546001 - Biol Psychiatry. 2011 Jul 1;70(1):97-105 – reference: 21945305 - Biol Psychiatry. 2012 Jun 1;71(11):1006-14 – reference: 21068319 - J Neurosci. 2010 Nov 10;30(45):15134-45 – reference: 21183487 - Brain. 2011 Feb;134(Pt 2):345-58 – reference: 25155877 - Mol Psychiatry. 2015 Jul;20(7):827-38 – reference: 11955958 - Schizophr Res. 2002 May 1;55(1-2):1-10 – reference: 19805354 - Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16663-8 – reference: 23612434 - Neuropsychopharmacology. 2013 Sep;38(10):1881-8 – reference: 21645555 - Behav Brain Res. 2011 Oct 10;224(1):15-22 – reference: 21129940 - Exp Toxicol Pathol. 2012 Jul;64(5):503-8 – reference: 23317110 - J Neuroimaging. 2014 Mar-Apr;24(2):101-10 – reference: 23446060 - Dev Neurosci. 2013;35(2-3):102-29 – reference: 9517569 - Glia. 1998 Apr;22(4):371-8 – reference: 20080054 - Trends Cogn Sci. 2010 Feb;14(2):72-80 – reference: 19631237 - Behav Brain Res. 2009 Dec 28;205(2):355-9 – reference: 19396156 - Nature. 2009 Jun 4;459(7247):663-7 – reference: 16261181 - Nat Rev Neurosci. 2005 Nov;6(11):877-88 – reference: 9798932 - J Neurochem. 1998 Nov;71(5):2071-8 – reference: 17194275 - J Clin Psychiatry. 2006 Dec;67(12):1954-67 – reference: 20388854 - Clin Cancer Res. 2010 May 1;16(9):2580-90 – reference: 16043134 - Biol Psychiatry. 2005 Dec 15;58(12):921-9 – reference: 16946833 - World Psychiatry. 2002 Oct;1(3):131-6 – reference: 16420437 - Eur J Neurosci. 2006 Jan;23(1):279-84 – reference: 24336286 - Nature. 2013 Dec 12;504(7479):272-6 – reference: 21703648 - Neuropharmacology. 2012 Mar;62(3):1273-89 – reference: 16571750 - J Neurosci. 2006 Mar 29;26(13):3434-43 – reference: 22246436 - Nat Neurosci. 2012 Mar;15(3):414-22, S1-2 – reference: 12372654 - Biol Psychiatry. 2002 Oct 15;52(8):823-30 – reference: 22243754 - Neuron. 2012 Jan 12;73(1):159-70 – reference: 21969553 - Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):E962-70 – reference: 16410648 - Dis Markers. 2006;22(1-2):83-93 – reference: 22958818 - Neuron. 2012 Sep 6;75(5):762-77 – reference: 21679927 - Biol Psychiatry. 2011 Sep 1;70(5):434-40 – reference: 19396159 - Nature. 2009 Jun 4;459(7247):698-702 – reference: 22383949 - PLoS One. 2012;7(2):e29341 – reference: 12742865 - Arch Gen Psychiatry. 2003 May;60(5):443-56 – reference: 19244511 - J Neurosci. 2009 Feb 25;29(8):2344-54 – reference: 17566708 - Schizophr Res. 2007 Aug;94(1-3):273-80 – reference: 18395805 - Trends Neurosci. 2008 May;31(5):234-42 – reference: 16730162 - Schizophr Res. 2006 Jul;85(1-3):245-53 – reference: 18988857 - Science. 2008 Nov 7;322(5903):967-70 – reference: 21801840 - Neuroimage. 2011 Oct 15;58(4):1081-9 – reference: 22956832 - J Neurosci. 2012 Sep 5;32(36):12411-20 – reference: 19036962 - J Neurosci. 2008 Nov 26;28(48):12691-9 – reference: 21126177 - Antioxid Redox Signal. 2011 Oct 1;15(7):2011-35 – reference: 19204281 - Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3561-6 – reference: 24309249 - Prog Brain Res. 2013;207:3-34 – reference: 12846992 - Ann N Y Acad Sci. 2003 Jun;991:251-71 – reference: 18684987 - Am J Physiol Cell Physiol. 2008 Oct;295(4):C849-68 – reference: 22764251 - J Neurosci. 2012 Jul 4;32(27):9429-37 – reference: 20087360 - Nat Rev Neurosci. 2010 Feb;11(2):100-13 – reference: 25505409 - Front Synaptic Neurosci. 2014 Nov 25;6:28 – reference: 23400808 - Curr Psychiatry Rep. 2013 Mar;15(3):346 – reference: 20080551 - Proc Natl Acad Sci U S A. 2010 Jan 19;107(3):1211-6 – reference: 25126763 - Harv Rev Psychiatry. 2014 Sep-Oct;22(5):251-65 – reference: 12462417 - Neurochem Res. 2002 Oct;27(10):1193-200 – reference: 21068826 - Nature. 2010 Nov 11;468(7321):187-93 – reference: 20463017 - J Biol Chem. 2010 Jul 16;285(29):22244-53 – reference: 23324948 - Curr Opin Psychiatry. 2013 Mar;26(2):172-87 – reference: 25758057 - Biol Psychiatry. 2015 Sep 15;78(6):396-402 – reference: 18322470 - Neuropsychopharmacology. 2008 Nov;33(12):2993-3009 – reference: 22406547 - Nat Neurosci. 2012 May;15(5):703-12 – reference: 24488531 - J Mol Neurosci. 2014 Aug;53(4):654-60 – reference: 19559404 - Biol Psychiatry. 2009 Aug 15;66(4):384-92 – reference: 11296301 - Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4746-51 – reference: 14720201 - J Neurochem. 2004 Feb;88(3):513-31 – reference: 8830852 - Neurosci Lett. 1996 Jun 21;211(2):93-6 – reference: 22937264 - Schizophr Res Treatment. 2011;2011:325789 – reference: 24971048 - Front Neurosci. 2014 Jun 12;8:145 – reference: 23671099 - Proc Natl Acad Sci U S A. 2013 May 28;110(22):9130-5 – reference: 19847447 - Acta Neuropathol. 2010 Jan;119(1):37-53 – reference: 19735056 - World J Biol Psychiatry. 2009;10(4 Pt 2):626-8 – reference: 24787547 - Int J Neuropsychopharmacol. 2014 Oct;17(10):1609-19 – reference: 20950668 - Prog Neurobiol. 2011 Jan;93(1):13-24 – reference: 24000072 - Metab Brain Dis. 2013 Dec;28(4):687-96 – reference: 21040854 - Neuron. 2010 Nov 4;68(3):557-69 – reference: 20855415 - Schizophr Bull. 2012 May;38(3):486-94 – reference: 23152631 - J Neurosci. 2012 Nov 14;32(46):16496-502 – reference: 12032331 - Proc Natl Acad Sci U S A. 2002 May 28;99(11):7610-5 – reference: 23790226 - Biol Psychiatry. 2013 Sep 15;74(6):427-35 – reference: 18063801 - Science. 2007 Dec 7;318(5856):1645-7 – reference: 18291369 - Exp Neurol. 2008 Apr;210(2):560-76 – reference: 23192314 - Psychopharmacology (Berl). 2013 Apr;226(3):531-40 – reference: 25189204 - Neuron. 2014 Sep 3;83(5):991-3 – reference: 21968533 - Acta Neuropathol. 2011 Nov;122(5):615-26 – reference: 25320232 - Sci Transl Med. 2014 Oct 15;6(258):258ra140 – reference: 24201233 - Clin Neuropharmacol. 2013 Nov-Dec;36(6):185-92 – reference: 24285906 - J Neurosci. 2013 Nov 27;33(48):19023-33 – reference: 17296559 - Neuron. 2007 Feb 15;53(4):591-604 – reference: 20124114 - Arch Gen Psychiatry. 2010 Feb;67(2):146-54 – reference: 22998866 - Neuron. 2012 Sep 20;75(6):963-80 – reference: 17298174 - PLoS Biol. 2007 Feb;5(2):e35 – reference: 23770240 - Cell Rep. 2013 Jun 27;3(6):1815-23 – reference: 18004285 - Neuropsychopharmacology. 2008 Aug;33(9):2187-99 – reference: 17555828 - Trends Neurosci. 2007 Jul;30(7):309-16 – reference: 14984887 - Schizophr Res. 2004 Apr 1;67(2-3):269-75 – reference: 20633320 - Int J Neuropsychopharmacol. 2011 Feb;14(1):123-30 – reference: 21923690 - Fundam Clin Pharmacol. 2012 Dec;26(6):712-21 |
SSID | ssj0014962 |
Score | 2.5238507 |
SecondaryResourceType | review_article |
Snippet | Schizophrenia is a neurodevelopmental disorder reflecting a convergence of genetic risk and early life stress. The slow progression to first psychotic episode... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 835 |
SubjectTerms | Animals Brain - growth & development Humans Invited Themed Neuronal Plasticity - physiology Oxidative Stress - physiology Schizophrenia - metabolism Schizophrenia - physiopathology Schizophrenia - therapy |
Title | Targeting Oxidative Stress and Aberrant Critical Period Plasticity in the Developmental Trajectory to Schizophrenia |
URI | https://www.ncbi.nlm.nih.gov/pubmed/26032508 https://www.proquest.com/docview/1689623548 https://www.proquest.com/docview/1717494966 https://pubmed.ncbi.nlm.nih.gov/PMC4466197 |
Volume | 41 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1745-1701 dateEnd: 20240930 omitProxy: true ssIdentifier: ssj0014962 issn: 0586-7614 databaseCode: DIK dateStart: 20060101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1745-1701 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0014962 issn: 0586-7614 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1745-1701 dateEnd: 20240930 omitProxy: true ssIdentifier: ssj0014962 issn: 0586-7614 databaseCode: RPM dateStart: 20060101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaWcuGCQOWxvGQkxGXxNk87OVZQVFjxUrdSb5GdOOoWSNBuFiHO_HBm4sRx2oIKlyhK7Gy888Uznvk8Q8gzLyzDgouC-QVXDANnLImTgoWBKIsgBJS01RveveeHx9Hbk_hkMvnlsJa2jZrnPy_dV_I_UoVrIFfcJfsPkrUPhQtwDvKFI0gYjleTcUvjxsX-hx-rwqTwPjKbP9Afvq_0GlRRM7P1DD7CW9UFVirC9MxogHc0R4c7hBv21_Ks9ea3pumRy8tzjdnRjZlyE3mjadw6YRerr7NPcxvp2OrKUHwMBXXwxFYbU5NqKT_LeraYu94IP7bM1X7SihPOBDcbQ-faTKoiihnmfXdn3ch30BU5U2hi0pf02tg4KC9M9F0SrPwUBocn6rvH40Gn9XH8c6rOEhBN6D3MzAMy0_0auR4IzrEOxqs3CxuLitK2LK0dWZepFbrvme57pvvYsrmwXDnPunXMmOUtcrNbf9B9A6bbZKKrXbKxQKIWSNQAiQKQaA8k2gOJGiDRAUh0VVEAEh0BiQ5Aok1NR3i5Q45fHyxfHrKuGgfLo0g0TCeRJxOPy1AqoVIsPBDkmO0RVDeoTfzMhcKAnQ58rSQMMw00MvK40mCUFuFdslPVlb5PqKcSmZS-5Fz7kcilTMvc06kM0lJ7fqmm5EX_T2Z5l6oeK6Z8yS6V25Q8t82_mRwtf2r4tBdLBrMohsZkpevtJvM5vGcQwvL9L20EADkFNPApuWdEaX8u4F4IiwnoLUZCtg0wi_v4TrU6bbO5I6HCT8WDqw7iIbkxfHiPyE6z3urHYBg36kmL299fJcRx |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Targeting+Oxidative+Stress+and+Aberrant+Critical+Period+Plasticity+in+the+Developmental+Trajectory+to+Schizophrenia&rft.jtitle=Schizophrenia+bulletin&rft.au=Do%2C+Kim+Q.&rft.au=Cuenod%2C+Michel&rft.au=Hensch%2C+Takao+K.&rft.date=2015-07-01&rft.issn=0586-7614&rft.eissn=1745-1701&rft.volume=41&rft.issue=4&rft.spage=835&rft.epage=846&rft_id=info:doi/10.1093%2Fschbul%2Fsbv065&rft.externalDBID=n%2Fa&rft.externalDocID=10_1093_schbul_sbv065 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0586-7614&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0586-7614&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0586-7614&client=summon |